Stocksigma LogoStocksigma Logo

Choksi Laboratories Board Approves ₹6.20 Crore Preferential Warrant Issue to Promoters

Choksi Laboratories' board approved the preferential issuance of up to 3,50,000 convertible equity warrants at Rs. 177 per warrant, aggregating to Rs

Choksi Laboratories Board Approves ₹6.20 Crore Preferential Warrant Issue to Promoters

Choksi Laboratories Ltd · Others (Uncategorized) · 19 Sept 2026, 11:29 pm

Choksi Laboratories Board Approves ₹6.20 Crore Preferential Warrant Issue to Promoters Choksi Laboratories' board approved the preferential issuance of up to 3,50,000 convertible equity warrants at Rs. 177 per warrant, aggregating to Rs. 6.195 crore, to promoter group entities (Sunil Choksi, Himika Choksi, and Stela Choksi). Each warrant is convertible into one equity share (face value Rs. 10) within 18 months, requiring 25% upfront subscription payment. Post-conversion, promoter holdings will increase, with Sunil Choksi rising from 7.51% to 9.89%. The issue is subject to shareholder approval at an EGM scheduled for 17th Oct'26.

Original exchange filing (PDF)

More announcements from Choksi Laboratories Ltd

All Choksi Laboratories Ltd announcements